Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

Front Pediatr · 2020 · PMC7892614 · PMID 33614543

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantp = 0.050actually significant

At TP2, with less data available, we observed only a borderline significant difference with worse OS in patients with FCM-MRD ≥ 0.01% ( p = 0.050; Supplementary Figure 6 ).

also in 11,409 other papers

borderline significanceno p-value reported

In the newest protocol SEHOP-PETHEMA-2013, a very low-risk group of patients with excellent outcome and no relapses was detected, with borderline significance.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.